The Silent Rise of Uterine Cancer: Why Are We Still in the Dark?
There’s a story that haunts me every time I think about the gaps in our healthcare system. It’s the story of Simone Crerar, a 56-year-old woman who went from complaining about abdominal pain to dying in her sleep in just nine weeks. What makes this particularly heartbreaking is that Simone’s symptoms were repeatedly missed, her case never escalated, and her diagnosis came too late. Metastatic uterine leiomyosarcoma—a rare, aggressive form of uterine cancer—had already spread to her liver. Personally, I think Simone’s story is a stark reminder of how little we know about uterine cancer, despite its rapidly rising incidence in Australia.
A Hidden Epidemic
Uterine cancer is the fastest-growing women’s cancer in Australia, with cases doubling over the past 25 years. Yet, here’s the shocking part: about nine in 10 women don’t even know it exists. From my perspective, this lack of awareness is a ticking time bomb. Early warning signs like abnormal vaginal bleeding, unexplained weight loss, and abdominal pain are often dismissed or misdiagnosed. What many people don’t realize is that up to 95% of uterine cancer cases are endometrial cancer, which is generally curable if caught early. But without awareness, women like Simone slip through the cracks.
The Role of Obesity, Diabetes, and Genetics
One thing that immediately stands out is the link between uterine cancer and lifestyle factors like obesity and diabetes. Dr. Anthony Richards explains that obesity increases the production of ‘unopposed estrogen,’ a key driver of endometrial cancer. Diabetes, with its elevated insulin levels, also plays a role. But here’s where it gets interesting: genetics are emerging as an independent risk factor. Dr. Tracy O’Mara’s research found that women with lifelong higher testosterone levels—regardless of BMI—are at greater risk. If you take a step back and think about it, this suggests that uterine cancer isn’t just about lifestyle; it’s about a complex interplay of biology and environment.
The Funding Gap and the Shame Factor
What this really suggests is that uterine cancer is a neglected disease. Between 2003 and 2020, Australia spent just $18 million on uterine cancer research compared to over $400 million for breast cancer. In my opinion, this disparity is inexcusable. But funding isn’t the only issue. There’s also the stigma. Abnormal vaginal bleeding—a hallmark symptom—is something many women feel too embarrassed to discuss. This raises a deeper question: How can we address a health crisis if we’re too uncomfortable to talk about it?
The Human Cost and the Way Forward
Simone Crerar’s brothers are now advocating for awareness, hoping their sister’s legacy can save lives. Their message is clear: women need to know the warning signs and push for answers if their symptoms are dismissed. But awareness alone isn’t enough. We need more research, better funding, and a cultural shift to break down the shame surrounding gynecological health. A detail that I find especially interesting is that younger women are increasingly being diagnosed, with rates rising fastest in those aged 25–44. This isn’t just a disease of older women—it’s a growing threat across generations.
Final Thoughts
If there’s one takeaway from Simone’s story, it’s this: uterine cancer is preventable in up to 60% of cases, but only if we act. Personally, I think it’s time to stop treating this as a ‘silent’ disease. We need to amplify the conversation, invest in research, and empower women to take control of their health. Because, as Simone’s story tragically illustrates, the cost of ignorance is far too high.
